- Home
- ALGS vs MKTW Comparison
ALGS vs MKTW Comparison
Compare ALGS & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- MKTW
- Stock Information
- Founded
- ALGS 2018
- MKTW 1999
- Country
- ALGS United States
- MKTW United States
- Employees
- ALGS N/A
- MKTW N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- MKTW Computer Software: Prepackaged Software
- Sector
- ALGS Health Care
- MKTW Technology
- Exchange
- ALGS Nasdaq
- MKTW Nasdaq
- Market Cap
- ALGS 50.4M
- MKTW 48.2M
- IPO Year
- ALGS 2020
- MKTW N/A
- Fundamental
- Price
- ALGS $7.84
- MKTW $20.12
- Analyst Decision
- ALGS Strong Buy
- MKTW
- Analyst Count
- ALGS 1
- MKTW 0
- Target Price
- ALGS $70.00
- MKTW N/A
- AVG Volume (30 Days)
- ALGS 125.8K
- MKTW 18.0K
- Earning Date
- ALGS 08-05-2025
- MKTW 08-13-2025
- Dividend Yield
- ALGS N/A
- MKTW 4.00%
- EPS Growth
- ALGS N/A
- MKTW 207.28
- EPS
- ALGS N/A
- MKTW 3.12
- Revenue
- ALGS $3,270,000.00
- MKTW $383,217,000.00
- Revenue This Year
- ALGS N/A
- MKTW N/A
- Revenue Next Year
- ALGS $51.55
- MKTW N/A
- P/E Ratio
- ALGS N/A
- MKTW $6.40
- Revenue Growth
- ALGS N/A
- MKTW N/A
- 52 Week Low
- ALGS $3.76
- MKTW $9.08
- 52 Week High
- ALGS $46.80
- MKTW $24.20
- Technical
- Relative Strength Index (RSI)
- ALGS 57.02
- MKTW 63.56
- Support Level
- ALGS $6.82
- MKTW $19.21
- Resistance Level
- ALGS $8.66
- MKTW $20.12
- Average True Range (ATR)
- ALGS 0.76
- MKTW 0.78
- MACD
- ALGS -0.06
- MKTW 0.05
- Stochastic Oscillator
- ALGS 55.49
- MKTW 87.99
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.